Related Experiment Videos

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing

C Lerman1, C Hughes, R T Croyle

  • 1Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC, 20007, USA. Lermanc@gunet.georgetown.edu

Preventive Medicine
|July 18, 2000
PubMed
Summary

Most BRCA1/2 gene mutation carriers do not opt for prophylactic surgery and many do not follow recommended cancer surveillance. Improved risk communication and decision-making support are needed for hereditary breast cancer management.

Related Concept Videos